| |
|
|
| Name: |
SR ONE CAPITAL MANAGEMENT LP |
| City: |
WAYNE |
| State: |
PA |
| Zip: |
19087 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
12 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
ACLX |
Arcellx, Inc. |
1 |
- |
$0.00 |
$153,939,000 |
2,346,630 |
39.54% |
-26,024,000 |
0 |
4.365 |
N/A |
|
|
SBTX |
Silverback Therapeutics, Inc. |
2 |
- |
$0.00 |
$50,482,000 |
4,012,903 |
12.97% |
8,146,000 |
0 |
2.318 |
N/A |
|
|
MLYS |
Mineralys Therapeutics, Inc. |
3 |
- |
$0.00 |
$49,672,000 |
3,127,933 |
12.76% |
24,845,000 |
1,111,111 |
6.29 |
N/A |
|
|
ZBIO |
Zenas Biopharma, Inc. |
4 |
- |
$9.58 |
$38,801,000 |
4,911,539 |
9.97% |
-1,425,000 |
0 |
11.753 |
N/A |
|
|
CRSP |
Crispr Therapeutics Ag |
5 |
- |
$47.49 |
$35,696,000 |
1,048,951 |
9.17% |
-5,591,000 |
0 |
1.485 |
N/A |
|
|
DSGN |
Design Therapeutics, Inc. |
6 |
- |
$0.00 |
$25,192,000 |
6,526,476 |
6.47% |
-15,076,000 |
0 |
11.734 |
N/A |
|
|
ALMS |
Alumis Inc. |
7 |
- |
$3.02 |
$12,034,000 |
1,959,896 |
3.09% |
-3,371,000 |
0 |
4.151 |
N/A |
|
|
OCS |
Oculis Holding Ord Shs |
8 |
New |
$0.00 |
$6,137,000 |
322,500 |
1.58% |
6,137,000 |
322,500 |
0.886 |
N/A |
|
|
NKTX |
Nkarta, Inc. |
9 |
- |
$0.00 |
$6,133,000 |
3,333,333 |
1.58% |
-2,167,000 |
0 |
4.724 |
N/A |
|
|
ORKA |
Oruka Therapeutics, Inc |
10 |
- |
$11.08 |
$4,415,000 |
430,330 |
1.13% |
-3,929,000 |
0 |
1.23 |
Diagnostic Substances |
|
|
KALA |
Kala Pharmaceuticals, Inc. |
11 |
- |
$4.62 |
$3,432,000 |
598,940 |
0.88% |
-725,000 |
0 |
12.992 |
N/A |
|
|
ENGN |
Engene Holdings Inc. |
12 |
- |
$3.66 |
$3,350,000 |
747,750 |
0.86% |
-1,623,000 |
0 |
1.693 |
N/A |
|
